Garmin hits a 12-year high on earnings. Blue Apron explores strategic options in the wake of another disappointing quarter. And Groupon plummets as it attempts to refocus its business. Motley Fool analysts Bill Mann and Emily Flippen discuss those stories and weigh in on the stock market’s real worry.
One in seven healthcare dollars in the United States are spent on diabetes and its related complications. That’s a huge burden for patients and for insurance companies. Thankfully, businesses are working to improve the outcomes for patients. Industry Focus Contributor Brian Feroldi joins the show to dive into three companies trying to improve diabetes treatment and monitoring: Dexcom, Tandem Diabetes, and Insulet.
How does a routine become habit-forming? One important part is figuring out a reward for the routine itself. For example, as Charles Duhigg (best-selling author of “The Power of Habit”) explains, the reward for brushing your teeth is not necessarily what you think it is.
Two years ago the market seemed a little volatile, so David picked 5 More Stocks to Feed the Next Bear. Where did that hungry bear go? A year before that, the presidential election had lots of people in a tizzy, so David picked 5 Stocks The World Needs Right Now. Did the world need them after all? Join David and guest Emily Flippen as we look back and review these stock picks.